Lentigo maligna (LM) is an in situ variant of melanoma. Our objective was to systematically
review clinical and histological clearance and recurrence rates of imiquimod treatment of LM …

Background The reported efficacy of imiquimod for lentigo maligna varies widely, without
consensus on tumor or treatment factors that can impact tumor clearance. Objective We …

Background The treatment of melanoma in situ (MIS), particularly the lentigo maligna (LM)
subtype, has been a controversial subject in the literature for over a decade. Surgical …

Surgical Treatments for Lentigo Maligna: A Review : Dermatologic Surgery Surgical
Treatments for Lentigo Maligna: A Review : Dermatologic Surgery Log in or Register …

Simple Summary The incidence of melanoma in situ has increased faster than invasive
melanoma over the last decades. Correctly managing these lesions is crucial. The gold …

Dermatoscopy (DE) is a noninvasive technique that allows a rapid and magnified in vivo
observation of the skin surface with the visualization of morphologic features invisible to the …

BACKGROUND The standard of care for melanoma in situ (MIS) is surgical removal by
surgical excision with a 5-mm margin or Mohs micrographic surgery, but as more and more …

Introduction The classical management of melanoma is surgery, but this can be challenging
because of several factors, such as age, body area, lesion size, among others. Topical …

Lentigo maligna is a type of in situ melanoma. It develops mainly in middle-aged and elderly
individuals on areas of the skin chronically exposed to sunlight. It progresses to its invasive …

Objective To determine the efficacy of imiquimod cream, 5%, in the treatment of lentigo
maligna (LM). Design Open-label before-and-after interventional study. Setting A …